| 000 | 01799 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513122833.0 | ||
| 264 | 0 | _c19970813 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0041-1337 | ||
| 024 | 7 |
_a10.1097/00007890-199707150-00020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoeckh, M | |
| 245 | 0 | 0 |
_aPlasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. _h[electronic resource] |
| 260 |
_bTransplantation _cJul 1997 |
||
| 300 |
_a108-13 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntigens, Viral _xblood |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aCytomegalovirus _xgenetics |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xprevention & control |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 |
_aGanciclovir _xtherapeutic use |
| 650 | 0 | 4 |
_aGraft Rejection _xvirology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukocytes, Mononuclear |
| 650 | 0 | 4 |
_aPharynx _xvirology |
| 650 | 0 | 4 |
_aPhosphoproteins _ximmunology |
| 650 | 0 | 4 |
_aPolymerase Chain Reaction _xmethods |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aViral Matrix Proteins _ximmunology |
| 650 | 0 | 4 | _aVirus Replication |
| 700 | 1 | _aGallez-Hawkins, G M | |
| 700 | 1 | _aMyerson, D | |
| 700 | 1 | _aZaia, J A | |
| 700 | 1 | _aBowden, R A | |
| 773 | 0 |
_tTransplantation _gvol. 64 _gno. 1 _gp. 108-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007890-199707150-00020 _zAvailable from publisher's website |
| 999 |
_c9213891 _d9213891 |
||